The Valley Desk

ArticleInternational immunopharmacologyPublished

EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Lewis Katz School of Medicine, Perelman School of Medicine, Temple University, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
International immunopharmacology
Published
Subject terms
Kidney; Animals; Mice, Inbred NZB; Humans; Mice; Lupus Nephritis; Lupus Erythematosus, Systemic; Disease Models, Animal; Fibrosis; Quinazolines; Interferon-alpha; Autoantibodies
PubMed ID
39079344
PubMed Central ID
PMC11456265
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal